BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 37101810)

  • 1. Antifungal Development and the Urgency of Minimizing the Impact of Fungal Diseases on Public Health.
    de Oliveira HC; Bezerra BT; Rodrigues ML
    ACS Bio Med Chem Au; 2023 Apr; 3(2):137-146. PubMed ID: 37101810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug Repurposing in Medical Mycology: Identification of Compounds as Potential Antifungals to Overcome the Emergence of Multidrug-Resistant Fungi.
    Peyclit L; Yousfi H; Rolain JM; Bittar F
    Pharmaceuticals (Basel); 2021 May; 14(5):. PubMed ID: 34065420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using inorganic nanoparticles to fight fungal infections in the antimicrobial resistant era.
    Huang T; Li X; Maier M; O'Brien-Simpson NM; Heath DE; O'Connor AJ
    Acta Biomater; 2023 Mar; 158():56-79. PubMed ID: 36640952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal Resistance, Metabolic Routes as Drug Targets, and New Antifungal Agents: An Overview about Endemic Dimorphic Fungi.
    Parente-Rocha JA; Bailão AM; Amaral AC; Taborda CP; Paccez JD; Borges CL; Pereira M
    Mediators Inflamm; 2017; 2017():9870679. PubMed ID: 28694566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening Repurposing Libraries for Identification of Drugs with Novel Antifungal Activity.
    Wall G; Lopez-Ribot JL
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32660991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal drugs: New insights in research & development.
    Nicola AM; Albuquerque P; Paes HC; Fernandes L; Costa FF; Kioshima ES; Abadio AKR; Bocca AL; Felipe MS
    Pharmacol Ther; 2019 Mar; 195():21-38. PubMed ID: 30347212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of current and emerging antifungal pharmacotherapy for invasive fungal infections.
    Mueller SW; Kedzior SK; Miller MA; Reynolds PM; Kiser TH; Krsak M; Molina KC
    Expert Opin Pharmacother; 2021 Jul; 22(10):1355-1371. PubMed ID: 33878996
    [No Abstract]   [Full Text] [Related]  

  • 8. Hydroxytyrosol (HT) Analogs Act as Potent Antifungals by Direct Disruption of the Fungal Cell Membrane.
    Diallinas G; Rafailidou N; Kalpaktsi I; Komianou AC; Tsouvali V; Zantza I; Mikros E; Skaltsounis AL; Kostakis IK
    Front Microbiol; 2018; 9():2624. PubMed ID: 30459736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging Antifungal Targets and Strategies.
    Ivanov M; Ćirić A; Stojković D
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungals.
    Campoy S; Adrio JL
    Biochem Pharmacol; 2017 Jun; 133():86-96. PubMed ID: 27884742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How urgent is the need for new antifungals?
    Stewart AG; Paterson DL
    Expert Opin Pharmacother; 2021 Oct; 22(14):1857-1870. PubMed ID: 34231434
    [No Abstract]   [Full Text] [Related]  

  • 12. Antifungal Drug Repurposing.
    Kim JH; Cheng LW; Chan KL; Tam CC; Mahoney N; Friedman M; Shilman MM; Land KM
    Antibiotics (Basel); 2020 Nov; 9(11):. PubMed ID: 33203147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repurposing non-antifungal drugs auranofin and pentamidine in combination as fungistatic antifungal agents against
    Lin J; Xiao X; Liang Y; Zhao H; Yu Y; Yuan P; Lu S; Ding X
    Front Cell Infect Microbiol; 2022; 12():1065962. PubMed ID: 36590591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Striving towards access to essential medicines for human and animal health; a situational analysis of access to and use of antifungal medications for histoplasmosis in Ethiopia.
    Robertson E; Abera C; Wood K; Deressa K; Mesfin S; Scantlebury C
    PLoS One; 2023; 18(3):e0278964. PubMed ID: 36893127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of antifungal susceptibility: Review of literature.
    Hadrich I; Ayadi A
    J Mycol Med; 2018 Sep; 28(3):574-584. PubMed ID: 29773435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antifungal pipeline: the need is established. Are there new compounds?
    Li D; She X; Calderone R
    FEMS Yeast Res; 2020 Jun; 20(4):. PubMed ID: 32353872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innovative therapies for invasive fungal infections in preclinical and clinical development.
    Yu Y; Albrecht K; Groll J; Beilhack A
    Expert Opin Investig Drugs; 2020 Sep; 29(9):961-971. PubMed ID: 32662681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New antifungal agents.
    Gupta AK; Tomas E
    Dermatol Clin; 2003 Jul; 21(3):565-76. PubMed ID: 12956208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 'Acridines' as New Horizons in Antifungal Treatment.
    Gabriel I
    Molecules; 2020 Mar; 25(7):. PubMed ID: 32218216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel avenues for identification of new antifungal drugs and current challenges.
    Jampilek J
    Expert Opin Drug Discov; 2022 Sep; 17(9):949-968. PubMed ID: 35787715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.